Abstract
Fenofibrate is a lipophilic drug used in hypercholesterolemia and hypertriglyceridemia as a lipid-regulating agent; however, it is characterized by poor water solubility and low dissolution rate, which result in a low oral bioavailability. In the present study, sericin/poly(ethylcyanoacrylate) nanospheres are synthesized by interfacial polymerization in aqueous media and investigated as a novel sericin-based delivery system for improved and enhanced oral bioefficacy of fenofibrate. The incorporation of sericin into the prepared cyanoacrylate nanoparticles and their spherical shape are confirmed by Lowry assay and scanning electron microscopy, respectively. Hydrophilic and mucoadhesive properties of the synthesized nanospheres are also evaluated. Finally, both in vitro release and in vivo studies are performed and the oral absorbable amount of fenofibrate is calculated to be higher than 70% when incorporated into the polymeric material, reducing the levels of total cholesterol (TC), triacylglycerols (TG), very low-density lipoproteins (VLDL), and low-density lipoproteins (LDL) compared to fenofibrate alone.
References
Sep 1, 1987·Circulation·D Steinberg
Jul 1, 1994·The Journal of Pharmacy and Pharmacology·P J Lowe, C S Temple
Nov 10, 1998·Circulation·B StaelsJ C Fruchart
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·C Leuner, J Dressman
Oct 11, 2003·Biotechnology Advances·Yu-Qing Zhang
Mar 4, 2005·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·L Harivardhan Reddy, R S R Murthy
Apr 19, 2005·Molecular Pharmaceutics·Nehal A KasimGordon L Amidon
Aug 7, 2007·International Review of Neurobiology·Carlo NucciLuigi A Morrone
Jun 14, 2008·Neuroscience·M T ViscomiM Molinari
Apr 23, 2009·Expert Opinion on Drug Delivery·Anja GrafThomas Rades
Feb 2, 2010·Journal of the American College of Cardiology·Benoit J ArsenaultKay-Tee Khaw
Oct 22, 2010·Drug Development and Industrial Pharmacy·Pankaj Ranjan KarnNataša Skalko-Basnet
Sep 29, 2011·Drugs·Kate McKeage, Gillian M Keating
Jan 17, 2012·Lipids in Health and Disease·Ederlan S FerreiraValdir A Neves
May 2, 2012·AAPS PharmSciTech·Kazi Mohsin
May 18, 2012·Cell and Tissue Research·Camelia S StancuAnca V Sima
Jan 30, 2013·Molecular Biotechnology·Malin BäckströmGunnar C Hansson
Apr 3, 2013·Carbohydrate Polymers·S DoakhanM B Moghadam
Apr 23, 2013·Colloids and Surfaces. B, Biointerfaces·Pradum Pundlikrao IgeSurendra G Gattani
Jun 12, 2013·Archives of Pharmacal Research·Young-Dae Cho, Young-Joon Park
Oct 15, 2013·Bioorganic & Medicinal Chemistry Letters·Adele ChimentoVincenzo Pezzi
Jun 10, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tuna YucelDavid L Kaplan
Citations
May 11, 2016·Pharmaceutical Research·Zhiqiang TianWei Wu
May 20, 2016·Korean Journal for Food Science of Animal Resources·Kibbeum SongJungkee Kwon
Feb 10, 2017·Drug Delivery·Luca ScrivanoFrancesco Puoci
Dec 22, 2017·Artificial Cells, Nanomedicine, and Biotechnology·Nidhi GuptaSurendra Nimesh
Jun 13, 2018·Journal of Biochemistry·Yuan LiVincenza Dolce
Dec 15, 2016·BioMed Research International·Regina Inês KunzMaria Raquel Marçal Natali
Jan 13, 2018·Soft Matter·Barbara CrivelliMaria Luisa Torre
Apr 25, 2020·Pharmaceutics·Giulia OrlandiSara Perteghella
Jan 24, 2021·Journal of Nanobiotechnology·Gitishree DasJayanta Kumar Patra
Jan 27, 2021·Biochimica Et Biophysica Acta. General Subjects·Paola LunettiLoredana Capobianco
Jun 23, 2020·Annales pharmaceutiques françaises·M ShitoleS Nangare
Jun 3, 2021·Pharmaceutics·Sara PerteghellaMaria Luisa Torre
Dec 10, 2018·ACS Biomaterials Science & Engineering·Annish JainSonia Kapoor